A post-authorisation, non-interventional, retrospective, drug-utilisation study to describe the pattern of use of lenalidomide in patients with myelodysplastic syndromes (MDS) (CC-5013-MDS-012)

ENCePP Code of conduct

No

Data sources

• Data source(s):
  Danish registries (access/analysis)
• Data source(s), other:
  - EUMDS - Myelodysplastic Syndrome; - Spanish Registry of MDS or RE SMD (Registro Español de Síndromes Mielodisplásicos); - Düsseldorf MDS Registry; - online French Registry of MDS; - Danish National Acute Leukemia Registry
• Data sources (types):
  Disease registry

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No